As of February 15, the Costa Rican Social Security Fund recorded 143,854 vaccine doses were given to children from 5 to 11 years of age, of which 111,235 are the first dose and 32,619 are second doses. Vaccination of children from 5 to 11 years of age began on January 11, 2022.
As of February 12, 2022, 6,951 cases have been reviewed with the Pfizer vaccine and 4,052 with the AstraZeneca vaccine, including adults.
The Ministry of Health noted that in the case of Pfizer, among the most reported reactions are point-of-application disorders, as well as central and peripheral nervous system disorders (mostly headache or migraine), followed by general disorders of the whole body (fever/fever, fatigue/tiredness, malaise), regardless of the age group or sex of the vaccinated person.
For AstraZeneca’s vaccine, a headache is also the most frequent reaction occurring, followed by general disorders of the whole body (chills, fever or low-grade fever), and disorders of the musculoskeletal system (myalgias and arthralgias), regardless of the age group or sex of the vaccinated person.
There are 64 serious cases associated with the Pfizer vaccine and 21 with the AstraZeneca vaccine, none of them coming from children in who are from 5 to 11 years old.
Of the total number of serious cases (85 cases), 31 reports are of deaths (28 reports correspond to the Pfizer vaccine and three cases to the AstraZeneca vaccine), most of them patients with multiple risk factors and/or other circumstances.
As of February 12, 0.1% of persons vaccinated against COVID-19 have reported any issues that can be attributed to the vaccine.
The National Center for Pharmacovigilance (CNFV) reminds everyone that in the event of a health issue following the application of the drug, it can and should be reported at the medical center where the immunization was administered or through the portal www.notificacentroamerica.net.
For more information about Covid-19 in Costa Rica, see the Health Ministry graphic below:
